Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Andrea M. Burden"'
Publikováno v:
Bone Reports, Vol 20, Iss , Pp 101730- (2024)
Observational studies of osteoporosis medications can provide critical real-world evidence (RWE) that fills knowledge gaps left by clinical trials. However, careful consideration of study design is needed to yield reliable estimates of association. I
Externí odkaz:
https://doaj.org/article/22e6c53567d3491e841c312a40566e12
Autor:
Maria L. Faquetti, Laura Slappendel, Hélène Bigonne, Francesca Grisoni, Petra Schneider, Georg Aichinger, Gisbert Schneider, Shana J. Sturla, Andrea M. Burden
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract INTRODUCTION Janus kinase (JAK) inhibitors were recently identified as promising drug candidates for repurposing in Alzheimer's disease (AD) due to their capacity to suppress inflammation via modulation of JAK/STAT signaling pathways. Beside
Externí odkaz:
https://doaj.org/article/32707a26a2ea43c8a6c975a581110aff
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Type 2 diabetes mellitus (T2DM) is associated with the development of chronic comorbidities, which can lead to high drug utilization and adverse events. We aimed to identify common comorbidity clusters and explore the progression over time i
Externí odkaz:
https://doaj.org/article/f788b9f6e961429399c767e9d3dd4571
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 520-526 (2022)
ABSTRACT: Objectives: In this study, we examined the toxicities, including poisoning and overdoses, with polyene, azole, flucytosine and echinocandin antifungals reported to the Swiss National Poison Centre. Methods: An observational cross-sectional
Externí odkaz:
https://doaj.org/article/f58ece1e67404cf39db7858066a486c3
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract As there are no clear on-target mechanisms that explain the increased risk for thrombosis and viral infection or reactivation associated with JAK inhibitors, the observed elevated risk may be a result of an off-target effect. Computational a
Externí odkaz:
https://doaj.org/article/b90a0be877b546d1a81f84dd7bbe2044
Autor:
Theresa Burkard, Dag Holmberg, Per Wretenberg, Anders Thorell, Thomas Hügle, Andrea M. Burden
Publikováno v:
Osteoarthritis and Cartilage Open, Vol 4, Iss 2, Pp 100249- (2022)
Objective: To investigate the associations between bariatric surgery and hip or knee arthroplasty, and secondary care hip or knee osteoarthritis (OA). Methods: We performed cohort studies using data from Swedish nationwide healthcare registries. Pati
Externí odkaz:
https://doaj.org/article/fff1de73c5bb408ab81a008b9f333f7c
Autor:
Natalia Konstantelos, Andrea M. Burden, Angela M. Cheung, Sandra Kim, Paul Grootendorst, Suzanne M. Cadarette
Publikováno v:
Pharmacy, Vol 11, Iss 2, p 53 (2023)
We identified inconsistency in fracture definitions in a prior review of studies that utilized claims data. Here, we aimed to compare fracture rates estimated using thirteen hip and seven radius/ulna fracture definitions. Our primary analysis compare
Externí odkaz:
https://doaj.org/article/e1bc7e6e89e34894a3f5740ae241982f
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/1910009d833149919a746d5333511587
Autor:
Enriqueta Vallejo-Yagüe, Julia N. Pfund, Theresa Burkard, Carole Clair, Raphael Micheroli, Burkhard Möller, Axel Finckh, Andrea M. Burden
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Objective To compare the likelihood of achieving remission between men and women with rheumatoid arthritis (RA) after starting their first biologic or targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD). Methods This cohort study in
Externí odkaz:
https://doaj.org/article/8092934a09b846b4ac5aa036baba3a97
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Glucocorticoid-induced osteoporosis (GIOP) leads to fractures in up to 40% of patients with chronic glucocorticoid (GC) therapy when left untreated. GCs rapidly increase fracture risk, and thus many patients with anticipated chronic GC exposures shou
Externí odkaz:
https://doaj.org/article/e0cb760630d14ff2a07b55baba0f8d5b